Real-world efficacy and safety of peptide receptor radionuclide therapy (PRRT) with 177Lu-Dotatate (Lutathera) (LU) in neuroendocrine tumors (NETs)

被引：0
|
作者：
Navarro Martin, M. [1 ]
Teran Brage, E. [1 ]
Campana-Diaz, E. [2 ]
Garcia-Talavera, P. [2 ]
Reguera Puertas, P. [1 ]
Rama-Alonso, S. [2 ]
Garijo-Martinez, M. C. [1 ]
Felix, L. C. [1 ]
Diaz Sanchez, P. [1 ]
Vidal Tocino, R. [1 ]
Fonseca Sanchez, E. [1 ]
机构：
[1] Univ Hosp Salamanca, Dept Med Oncol, Salamanca, Spain
[2] Univ Hosp Salamanca, Dept Nucl Med, Salamanca, Spain
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.05.227
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
219P
引用
收藏
页码：S95 / S95
页数：1
相关论文
共 50 条
  • [31] Efficacy and Safety of 177Lu-DOTATATE in Lung Neuroendocrine Tumors: A multicenter study
    Mitjavila Casanovas, M.
    Pubul, V.
    Bello, P.
    Miguel, B.
    Cano, J.
    Balaguer, D.
    Garcia-Burillo, A.
    Marino Mendez, A.
    Rodeno, E.
    Custodio, A.
    Pineiro, A.
    Garcia-Canamaque, L.
    Castellon, M.
    Orduna, M.
    Carmona-Bayonas, A.
    Jimenez-Fonseca, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S103 - S104
  • [32] Evaluation of Kidney Dose in Neuroendocrine Tumors Patients after Peptide Receptor Radionuclide Therapy using 177Lu-DOTATATE
    Hidayati, N. R.
    Poon, A.
    Willowson, K.
    Eslick, E.
    Ryu, H.
    Bailey, D. L.
    ATOM INDONESIA, 2019, 45 (03) : 147 - 152
  • [33] Safety and efficacy of peptide radionuclide therapy (PRRT) with 177Lu-DOTATATE for Japanese patients with neuroendocrine neoplasm (NEN): A single-center retrospective study
    Okamoto, K.
    Hijioka, S.
    Goto, Y.
    Honma, Y.
    Hirano, H.
    Shoji, H.
    Sudo, K.
    Shimoi, T.
    Yonemori, K.
    Ito, K.
    Morizane, C.
    Okusaka, T.
    JOURNAL OF NEUROENDOCRINOLOGY, 2024, 36 : 211 - 211
  • [34] Data collection procedures for bone marrow dosimetry in peptide receptor radionuclide therapy with 177Lu-DOTATATE on neuroendocrine tumors
    Frederiksen, M. H. B.
    Klausen, T. L.
    de Nijs, R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S631 - S631
  • [35] 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors: Review of Treatment Workflow and Challenging Clinical Scenarios
    Abiodun-Ojo, Olayinka
    Shin, Muheon
    Chopra, Jigyasa
    Muzahir, Saima
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [36] Efficacy and Safety of 177Lu-DOTATATE in Lung Neuroendocrine Tumors: A Bicenter study
    Zidan, Lamiaa
    Iravani, Amir
    Oleinikov, Kira
    Ben-Haim, Simona
    Gross, David J.
    Meirovitz, Amichay
    Maimon, Ophra
    Akhurst, Tim
    Michael, Michael
    Hicks, Rodney J.
    Grozinsky-Glasberg, Simona
    Kong, Grace
    JOURNAL OF NUCLEAR MEDICINE, 2022, 63 (02) : 218 - 225
  • [37] Peptide Receptor Radionuclide Therapy by 177Lu-DOTATATE of a Secreting Cervical Paraganglioma
    Deville, Agathe
    Pinigina, Iuliia
    Al Mansour, Laure
    Abeillon, Juliette
    Tordo, Jeremie
    CLINICAL NUCLEAR MEDICINE, 2022, 47 (01) : E71 - E73
  • [38] Radiation safety assessment of 177Lu-DOTATATE Intra-Arterial peptide receptor therapy (PRRT)
    Chauhan, M.
    Jha, A. K.
    Mithun, S.
    Parab, R.
    Nautiyal, A.
    Rangarajan, V.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S385 - S386
  • [39] Efficacy and Safety of Lu-177 DOTATATE Peptide Receptor Radionuclide Therapy in Patients with Unresectable or Metastatic Neuroendocrine Tumors in Korea
    Yeokyeong Shin
    Bo Hyun Moon
    Baek-Yeol Ryoo
    Heung-Moon Chang
    Kyu-pyo Kim
    Yong Sang Hong
    Tae Won Kim
    Jin-Sook Ryu
    Yong-il Kim
    Changhoon Yoo
    Targeted Oncology, 2024, 19 : 41 - 49
  • [40] Radiation Safety Assessment of 177Lu-DOTATATE Intra-arterial Peptide Receptor Therapy (PRRT)
    Chauhan, Manoj Kumar Hariram
    Jha, Ashish Kumar
    Mithun, Sneha
    Parab, Rutuja Dasharath
    Dwivedi, Pooja
    Puranik, Ameya D.
    Gala, Kunal Bharat
    Shetye, Nitin Sudhakar
    Kulkarni, Suyash
    Rangarajan, Venkatesh
    INDIAN JOURNAL OF NUCLEAR MEDICINE, 2024, 39 (04): : 254 - 258
12345